Cervical Cancer Screening and Management

Screening and Follow-up Recommendations

For a patient with a negative Pap smear and positive HPV test, the recommended next step is to repeat both HPV testing and cytology in 12 months, as suggested by the American College of Obstetricians and Gynecologists, based on guidelines from the MMWR Recommendations and Reports 1
Repeat co-testing at 12 months (HPV test plus Pap smear) is the preferred approach, allowing time to determine if the HPV infection will persist or clear naturally, and avoids unnecessary colposcopy for transient infections, according to the MMWR Recommendations and Reports 2, 1
If positive for HPV types 16 or 18, proceed directly to colposcopy, as these high-risk types have a stronger association with cervical cancer, as recommended by the MMWR Recommendations and Reports 1
For women ≥30 years, the above algorithm applies, and for women <30 years, HPV testing is generally not recommended for primary screening, but if performed and positive with negative cytology, follow the same 12-month follow-up protocol, as suggested by the MMWR Recommendations and Reports 1

Ensure all test results and follow-up plans are clearly documented, including HPV test result, Pap test result, follow-up plan with specific timeframe, and patient education provided regarding the significance of results, as recommended by the MMWR Recommendations and Reports 2

The 2019 American Society for Colposcopy and Cervical Pathology (ASCCP) risk-based management guidelines support this approach, focusing on the patient's risk of developing cervical precancer rather than specific test results alone, as reported in the MMWR Recommendations and Reports 1
The American College of Obstetricians and Gynecologists recommends avoiding overtreatment, undertreatment, and poor documentation, and developing systems to track patients who need repeat testing, based on guidelines from the MMWR Recommendations and Reports 1, 2